The ExTINGUISH Trial

This is the first-ever Clinical Trial for a promising new drug, Inebilizumab, to treat anti-NMDA receptor encephalitis, and will be funded by the National Institutes of Health (NIH).

Category: Business > Manufacturing > Pharmaceutical > Clinical-trials Upgrade Options